news

June 21 2016
ContraVir Doses First Patients in Head-to-Head Study of CMX157 vs. Viread® for Treating Hepatitis B

June 16 2016
ContraVir Pharmaceuticals Expands Patient Enrollment Criteria for Ongoing Phase 3 Clinical Study of FV-100 for Treating Shingles

June 16 2016
Vaccinogen Announces Filing of Oncavert® Patent Application


 

events

June 21-22 2016
JMP Securities Life Sciences Conference

July 12-14 2016
Biotech CEO Summit

July 12-13 2016
Cantor Fitzgerald’s 2nd Annual Healthcare Conference

Aug 10-11 2016
CanaccordGenuity Growth Conference

Sept 9 2016
BioCentury's NewsMakers in the Biotech Industry


 

spotlight